# FDA Inspection 1198219 - Vitalant - February 07, 2023

Source: https://www.keypedia.com/records/fda_inspections/vitalant/bff2e4ec-6e15-4b58-8ea4-cdba89fb044a
Source feed: FDA_Inspections

> FDA Inspection 1198219 for Vitalant on February 07, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198219
- Company Name: Vitalant
- Inspection Date: 2023-02-07
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1309896 - 2026-03-24](https://www.keypedia.com/records/fda_inspections/vitalant/f2c24c8d-3416-4a84-810b-d897d9780f1a)
- [FDA Inspection 1309896 - 2026-03-24](https://www.keypedia.com/records/fda_inspections/vitalant/a02f3c34-9220-43fa-93e1-e24aac4cad60)
- [FDA Inspection 1198219 - 2023-02-07](https://www.keypedia.com/records/fda_inspections/vitalant/e5acf489-7fd9-4222-be30-2a73765e85bb)
- [FDA Inspection 1062118 - 2018-07-31](https://www.keypedia.com/records/fda_inspections/vitalant/25cd98ae-d81c-41c6-82f0-bf3883369edd)
- [FDA Inspection 962801 - 2016-03-15](https://www.keypedia.com/records/fda_inspections/vitalant/77c163d8-493d-4268-8d99-14d4d599acd6)

Company: https://www.keypedia.com/companies/vitalant/5173d121-0a56-41f8-a996-5dfdb0e09d7c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d